Cabozantinib 40mg Tablet: Multi-Targeted Tyrosine Kinase Inhibition for Advanced Solid Tumors Are you searching for a reliable Cabozantinib 40mg Tablet exporter from India? Ernest Oncology, a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of targeted therapies. We maintain a secure supply chain for London, Washington, Canberra, and Johannesburg, ensuring medications reach institutional pharmacies with 100% integrity. 1. Mechanism of Action: Multi-Pathway Inhibition Tyrosine Kinase Inhibition: It inhibits several receptor tyrosine kinases, including MET, VEGFR-1, -2, and -3, and AXL. Anti-Angiogenesis: By blocking VEGFR receptors, it prevents the tumor from forming new blood vessels needed for growth. Signal Interruption: It disrupts pathways involved in cancer cell survival, metastasis, and the development of drug resistance. 2. Therapeutic Indications Advanced Renal Cell Carcinoma (RCC): Effective for kidney cancer, including as first-line therapy or after prior anti-angiogenic treatment. Hepatocellular Carcinoma (HCC): Used for liver cancer patients previously treated with sorafenib. Differentiated Thyroid Cancer (DTC): Specifically for patients with radioactive iodine-refractory thyroid cancer that has progressed. Medullary Thyroid Cancer (MTC): Utilized for progressive, metastatic thyroid cancer. 3. Administration and Clinical Handling Standard Dosing: The 40mg dose is often used in combination with immunotherapy (e.g., Nivolumab) or as a dose-adjusted monotherapy. Timing: Take on an empty stomach. Do not eat for at least 2 hours before and 1 hour after dosing. Consistency: Swallow tablets whole; do not crush, split, or chew. Dietary Restriction: Avoid grapefruit products, as they can dangerously increase drug levels in the blood. 4. Clinical Side Effects & Safety Monitoring Hypertension: Blood pressure must be monitored regularly; anti-hypertensive therapy is often required. Hand-Foot Skin Reaction (HFSR): Redness, swelling, and pain on palms/soles; early management is vital. Gastrointestinal Health: Risk of severe diarrhea, nausea, and stomatitis. Hemorrhage & Perforation: Patients must be monitored for signs of internal bleeding or GI perforations. Wound Healing: Treatment must be discontinued at least 3 weeks prior to elective surgery. 5. Why Source from Ernest Oncology? Verified Authenticity: Direct sourcing from high-integrity manufacturers with full batch-specific COA. Logistics Authority: Expert handling of international export regulations and cold-chain maintenance for the USA, UK, and Australia. Wholesale Solutions: Competitive bulk pricing for hospital groups and regional distributors. Regulatory Compliance: Shipments include GMP certificates and comprehensive B2B documentation. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 📦 Business Type: Exporter | Bulk Supplier | Distributor 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383
Washington, USA
08048034998
+919405476170
Chat with us
Chat with us